Dermalogica Prioritizes Skin Longevity and AI-Generated Peptides for 2027

According to reporting from Cosmetics Business, Dermalogica is moving beyond standard anti-aging by integrating biotechnology and mitochondrial health into its upcoming R&D cycle. The Unilever-owned brand plans to debut AI-designed functional peptides by 2027 while expanding its

According to reporting from Cosmetics Business, Dermalogica is moving beyond standard anti-aging by integrating biotechnology and mitochondrial health into its upcoming R&D cycle. The Unilever-owned brand plans to debut AI-designed functional peptides by 2027 while expanding its